<DOC>
	<DOC>NCT01764945</DOC>
	<brief_summary>The objective of the current study is to investigate the relative bioavailability of two different doses of BI 201335, administered as soft gelatine capsule in comparison to the equivalent doses of three different oral solution per dose of BI 201335.</brief_summary>
	<brief_title>Relative Bioavailability of BI 201335 Capsule Versus Three Different Oral Solutions</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Inclusion criteria: 1. Healthy male and female subjects Exclusion criteria: Any relevant deviation from healthy conditions</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>